By a 5-3 vote, the Supreme Court held that pharmaceutical pay-for-delay deals aren't presumptively illegal under antitrust laws, but the government can still try to make a case that individual settlements are anticompetitive. In other words, the pharma industry will be keeping its lawyers very busy.
FTC Calls Pay-for-Delay Ruling 'Significant Victory'
The National Law Journal
June 17, 2013